Metabolic syndrome and its risk factors among middle aged population of Iran, a population based study

Diabetes & Metabolic Syndrome
Hossein EbrahimiAkbar Fotouhi

Abstract

To determine the prevalence of metabolic syndrome (MS) and its risk factors in a middle-aged population in Iran. The sample was 5190 individuals aged 40-64 years participated in the first phase of the Shahroud eye cohort study. Prevalence of MS was determined in terms of the age and sex. Other variables were evaluated by using simple and multiple logistic regression methods. The prevalence of MS was 10.88% in men, 13.03% in women and 12.14% in total. The prevalence proportion increased with increasing age. In multivariate logistic regression model, age (odds ratio (OR)=1.06), education (OR=0.98) and smoking (OR=0.50), had significant effects on MS. In this model, gender, marital status and economic status had no significant effect on MS. Higher prevalence of obesity and overweight in non-smokers (79.9%) compare to smokers (47.4%, P<0.001), indicated that the association of smoking and MS is confounded. Despite the low prevalence of MS in this study, older age was associated with increased risk of developing MS and higher education was associated with decreased this risk, therefore health education, changing the lifestyle, and taking greater attention in elderly is needed in order to prevent the MS and its complications.

References

May 10, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·K G M M AlbertiJ Shaw
Jul 10, 2007·Journal of Diabetes and Its Complications·Yousef KhaderKamel Ajlouni
Dec 4, 2008·The Journal of Clinical Endocrinology and Metabolism·Anoop Misra, Lokesh Khurana
Nov 7, 2009·Experimental Diabetes Research·F SharifiM Dinmohammadi
Dec 18, 2010·Archives of Gerontology and Geriatrics·Gamze AkbulutNevin Sanlier
Jan 20, 2012·BMC Public Health·Subrina JesminTetsu Watanabe
Oct 20, 2012·International Journal of Epidemiology·Akbar FotouhiMehdi Khabazkhoob
Mar 19, 2013·Journal of Diabetes and Metabolic Disorders·Hajieh ShahbazianArmaghan Moravej Aleali
Jun 6, 2013·Metabolic Syndrome and Related Disorders·Arturo Corbatón-AnchueloUNKNOWN Segovia Insulin Resistance Study Group
Apr 5, 2014·Journal of Clinical and Diagnostic Research : JCDR·Maureen Jepkorir CheserekGuo-Wei Le
May 27, 2014·Journal of Diabetes and Metabolic Disorders·Homeira RashidiMarzieh Ghasemi
Jul 24, 2014·Journal of Diabetes and Metabolic Disorders·Victor MogreRobert Abedandi
Aug 13, 2014·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Otmane El BriniBouchra Benazzouz
Aug 21, 2014·PloS One·Rogelio SalasAntoni Sureda
Sep 16, 2014·Diabetes & Metabolic Syndrome·Prakash C DeedwaniaArvind Gupta
Nov 13, 2014·Revista brasileira de epidemiologia = Brazilian journal of epidemiology·Edna Cunha VieiraErika Aparecida da Silveira

❮ Previous
Next ❯

Citations

Dec 24, 2019·Work : a Journal of Prevention, Assessment, and Rehabilitation·Vahid GharibiMohammad Khammarnia
Jun 25, 2020·International Journal of Preventive Medicine·Azad FatahiZahra Cheraghi
Jan 18, 2020·Journal of Research in Medical Sciences : the Official Journal of Isfahan University of Medical Sciences·Hossein EbrahimiAkbar Fotouhi
Apr 17, 2021·International Journal of Endocrinology·Mohammadreza NaghipourFariborz Mansour-Ghanaei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Carotid Artery Diseases

Carotid artery disease is a group of pathological conditions of the carotid artery. Discover the latest research on carotid artery disease here.